Wright Medical Group NV (WMGI) Expected to Post Quarterly Sales of $186.21 Million

Wall Street brokerages expect Wright Medical Group NV (NASDAQ:WMGI) to post $186.21 million in sales for the current quarter, according to Zacks Investment Research. Fifteen analysts have made estimates for Wright Medical Group’s earnings. The highest sales estimate is $188.08 million and the lowest is $184.03 million. Wright Medical Group reported sales of $170.50 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 9.2%. The firm is scheduled to announce its next earnings report after the market closes on Wednesday, November 7th.

According to Zacks, analysts expect that Wright Medical Group will report full-year sales of $821.07 million for the current year, with estimates ranging from $816.09 million to $829.53 million. For the next financial year, analysts forecast that the company will report sales of $925.59 million, with estimates ranging from $892.67 million to $972.47 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Wright Medical Group.

Wright Medical Group (NASDAQ:WMGI) last announced its quarterly earnings results on Wednesday, August 8th. The medical device company reported ($0.03) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.06) by $0.03. Wright Medical Group had a negative net margin of 24.74% and a negative return on equity of 1.94%. The company had revenue of $205.40 million for the quarter, compared to analysts’ expectations of $197.20 million. During the same period in the prior year, the company posted ($0.07) EPS. Wright Medical Group’s revenue was up 14.3% compared to the same quarter last year.

Several analysts have issued reports on WMGI shares. Piper Jaffray Companies increased their target price on shares of Wright Medical Group to $32.00 and gave the stock an “overweight” rating in a research note on Thursday, August 9th. Cantor Fitzgerald increased their target price on shares of Wright Medical Group from $30.00 to $35.00 and gave the stock an “overweight” rating in a research note on Thursday, August 9th. Oppenheimer set a $28.00 target price on shares of Wright Medical Group and gave the stock a “hold” rating in a research note on Thursday, August 9th. Stifel Nicolaus started coverage on shares of Wright Medical Group in a research note on Tuesday, August 21st. They issued a “buy” rating and a $34.00 target price on the stock. Finally, ValuEngine upgraded shares of Wright Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, September 19th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Wright Medical Group presently has an average rating of “Buy” and a consensus price target of $31.64.

In other news, SVP Jennifer S. Walker sold 11,466 shares of the stock in a transaction on Thursday, August 9th. The shares were sold at an average price of $28.60, for a total value of $327,927.60. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Peter Cooke sold 13,478 shares of the stock in a transaction on Friday, November 2nd. The stock was sold at an average price of $28.03, for a total transaction of $377,788.34. The disclosure for this sale can be found here. Insiders sold a total of 27,783 shares of company stock worth $783,028 in the last three months. Insiders own 4.00% of the company’s stock.

Large investors have recently modified their holdings of the company. Cortina Asset Management LLC bought a new position in shares of Wright Medical Group in the 2nd quarter worth $221,000. Schwab Charles Investment Management Inc. grew its holdings in shares of Wright Medical Group by 4.5% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 552,912 shares of the medical device company’s stock valued at $14,354,000 after purchasing an additional 23,911 shares during the last quarter. Tygh Capital Management Inc. grew its holdings in shares of Wright Medical Group by 78.1% during the 2nd quarter. Tygh Capital Management Inc. now owns 241,775 shares of the medical device company’s stock valued at $6,276,000 after purchasing an additional 105,998 shares during the last quarter. Sivik Global Healthcare LLC bought a new position in shares of Wright Medical Group during the 2nd quarter valued at $2,204,000. Finally, Principal Financial Group Inc. grew its holdings in shares of Wright Medical Group by 7.0% during the 1st quarter. Principal Financial Group Inc. now owns 92,781 shares of the medical device company’s stock valued at $1,841,000 after purchasing an additional 6,084 shares during the last quarter.

NASDAQ WMGI traded up $0.23 on Friday, hitting $27.70. The stock had a trading volume of 183,250 shares, compared to its average volume of 1,196,716. Wright Medical Group has a 52-week low of $19.01 and a 52-week high of $29.50. The company has a debt-to-equity ratio of 1.87, a current ratio of 2.06 and a quick ratio of 1.57. The stock has a market capitalization of $2.96 billion, a PE ratio of -126.05 and a beta of 1.06.

About Wright Medical Group

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Featured Article: How can you know how many shares are floating?

Get a free copy of the Zacks research report on Wright Medical Group (WMGI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply